116 related articles for article (PubMed ID: 27225983)
1. The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of Cancers.
Wang CD; Sun Y; Chen N; Huang L; Huang JW; Zhu M; Wang T; Ji YL
Sci Rep; 2016 May; 6():26973. PubMed ID: 27225983
[TBL] [Abstract][Full Text] [Related]
2. The effect of catalase C262T gene polymorphism in susceptibility to ovarian cancer in Kermanshah province, Western Iran.
Moradi MT; Khazaei M; Khazaei M
J Obstet Gynaecol; 2018 May; 38(4):562-566. PubMed ID: 29421935
[TBL] [Abstract][Full Text] [Related]
3. Catalase C262T genetic variation and cancer susceptibility: A comprehensive meta-analysis with meta-regression and trial sequential analysis.
Barek MA; Jafrin S; Aziz MA; Islam MS
Int J Biol Markers; 2022 Sep; 37(3):227-240. PubMed ID: 35645161
[TBL] [Abstract][Full Text] [Related]
4. The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis.
Shen Y; Li D; Tian P; Shen K; Zhu J; Feng M; Wan C; Yang T; Chen L; Wen F
Medicine (Baltimore); 2015 Apr; 94(13):e679. PubMed ID: 25837760
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the relation between catalase
Eras N; Türkoz G; Tombak A; Tiftik N; Yalin S; Berkoz M; Erden S; Akbas E
Arch Med Sci; 2021; 17(4):928-933. PubMed ID: 34336022
[TBL] [Abstract][Full Text] [Related]
6. Two common functional catalase gene polymorphisms (rs1001179 and rs794316) and cancer susceptibility: evidence from 14,942 cancer cases and 43,285 controls.
Liu K; Liu X; Wang M; Wang X; Kang H; Lin S; Yang P; Dai C; Xu P; Li S; Dai Z
Oncotarget; 2016 Sep; 7(39):62954-62965. PubMed ID: 27449288
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the 389C>T polymorphism (rs769217) in the catalase (CAT) gene and the risk of vitiligo: an update by meta-analysis.
He J; Li X; Li Y; Ren B; Sun J; Zhang W; Li W
Australas J Dermatol; 2015 Aug; 56(3):180-5. PubMed ID: 25139332
[TBL] [Abstract][Full Text] [Related]
8. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
[TBL] [Abstract][Full Text] [Related]
9. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphism of CAT C-262 T and Susceptibility to Breast Cancer, a Case-Control Study and Meta-Analysis of the Literatures.
Saadat M; Saadat S
Pathol Oncol Res; 2015 Apr; 21(2):433-7. PubMed ID: 25248722
[TBL] [Abstract][Full Text] [Related]
11. Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-analysis.
Hu J; Feng F; Zhu S; Sun L; Li G; Jiang N; Shang Z; Niu Y
Gene; 2015 Mar; 558(2):265-70. PubMed ID: 25576221
[TBL] [Abstract][Full Text] [Related]
12. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M; Zou Y; Bai Y; Li M
J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
[TBL] [Abstract][Full Text] [Related]
13. Association Between WRN Cys1367Arg (T>C) and Cancer Risk: A Meta-analysis.
Wang B; Li G; Sun F; Dong N; Sun Z; Jiang D
Technol Cancer Res Treat; 2016 Feb; 15(1):20-7. PubMed ID: 25468760
[TBL] [Abstract][Full Text] [Related]
14. The polymorphism of catalase T/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis.
Lv YJ; Liao WJ; Luan Q; Wang H; Wang L; Li Q
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):955-8. PubMed ID: 21054578
[TBL] [Abstract][Full Text] [Related]
15. STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.
Xu L; Zhou X; Jiang F; Xu L; Yin R
Cancer Epidemiol; 2014 Apr; 38(2):111-7. PubMed ID: 24252226
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
Zheng H; Zhao Y
Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
[TBL] [Abstract][Full Text] [Related]
17. PSCA rs2294008 Polymorphism with Increased Risk of Cancer.
Geng P; Li J; Wang N; Ou J; Xie G; Liu C; Zhao X; Xiang L; Liao Y; Liang H
PLoS One; 2015; 10(8):e0136269. PubMed ID: 26308216
[TBL] [Abstract][Full Text] [Related]
18. The role of CYBA (p22phox) and catalase genetic polymorphisms and their possible epistatic interaction in cervical cancer.
Castaldo SA; da Silva AP; Matos A; Inácio Â; Bicho M; Medeiros R; Alho I; Bicho MC
Tumour Biol; 2015 Feb; 36(2):909-14. PubMed ID: 25307973
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
Tavakolpour S
Mult Scler Relat Disord; 2016 Jul; 8():66-73. PubMed ID: 27456877
[TBL] [Abstract][Full Text] [Related]
20. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
